Presentation
13 March 2024 Guidance and evaluation of IRE treatment in colorectal cancer using integrated OCT-NIRF-IVUS endoscopy system
Author Affiliations +
Proceedings Volume PC12820, Endoscopic Microscopy XIX; PC1282001 (2024) https://doi.org/10.1117/12.3000069
Event: SPIE BiOS, 2024, San Francisco, California, United States
Abstract
Colorectal cancer (CRC) ranks third globally in terms of prevalence, accounting for 10% of cancer cases and deaths each year. Irreversible electroporation (IRE) offers promise for treating CRC by selectively destroying tumor cells while minimizing harm to healthy tissue. However, the lack of effective guidance and evaluation methods hampers the achievement of complete tumor ablation. To address this, integrated OCT, US, and NIRF endoscopy enable real-time imaging of colorectal tumors, facilitating precise IRE treatment and evaluation of outcomes. In this study, we used an integrated imaging system to precisely guide and evaluate the implementation of IRE therapy in CRC.
Conference Presentation
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Ruiming Kong, Fenggang Ren, Zhuoquan Chen, Yuting Song, Bing Wang, and Teng Ma "Guidance and evaluation of IRE treatment in colorectal cancer using integrated OCT-NIRF-IVUS endoscopy system", Proc. SPIE PC12820, Endoscopic Microscopy XIX, PC1282001 (13 March 2024); https://doi.org/10.1117/12.3000069
Advertisement
Advertisement
KEYWORDS
Ablation

Colorectal cancer

Endoscopy

Tumors

Error control coding

System integration

Biomedical applications

Back to Top